New hope drug enters human testing for tough cancers
NCT ID NCT06167486
Summary
This is the first human study testing a new cancer drug called SG2918. It aims to find a safe dose and check for early signs that it might help control advanced cancers. The study involves 17 patients whose cancers have stopped responding to standard treatments or who have no other options left.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, 400000, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450003, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410031, China
-
Shanghai first maternity and infant hospital
Shanghai, Shanghai Municipality, 200126, China
-
Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, 30013, China
-
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, 310005, China
Conditions
Explore the condition pages connected to this study.